Kestra Medical Technologies, Ltd.

KMTS Healthcare Medical Instruments & Supplies

Kestra Medical Technologies, Ltd.’s revenue for fiscal 2026 (year ended April 2026) was $95.1 million, up 59.0% from fiscal 2025. In the quarter to July 2026, revenue grew 59.9%, EPS fell 50.0%, free cash flow fell 17.8% and total debt rose 74.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

27.24 1.44 −5.02%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−8.8×
Dividend yield
—
F-score
4/9
Altman Z
3.87
Beneish M
1.67
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
ROE

+6 more TTM periods

0.00% (366.07%) (56.60%) (73.74%)
ROA
(109.08%) (67.67%) (40.24%) (48.85%)
ROIC
(271.86%) (235.95%) (79.54%) (93.49%)
Return on Tangible Assets
(65.45%) (44.28%) (56.96%) (62.02%)
Average Days of Receivables
51.18 55.41 55.80 52.69
Free Cash Flow per Share
(2.22) (2.15) (2.16) (2.10)
Free Cash Flow
(114.18) (120.01) (116.94) (123.06)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Oct 2026